Sign In
Buy LIFE
$16.89
-0.375 (-2.17%)
At Close: Jun 03, 2026
aTyr Pharma to Webcast Conference Call Reporting First Quarter 2020 Financial Results
12:03pm, Wednesday, 06'th May 2020
SAN DIEGO, May 06, 2020 -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel.
aTyr Pharma Announces Publication of Two Abstracts in American Journal of Respiratory and Critical Care Medicine
12:03pm, Tuesday, 05'th May 2020
SAN DIEGO, May 05, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways
Oppenheimer Remains a Buy on aTyr Pharma (LIFE)
10:44am, Tuesday, 28'th Apr 2020
Oppenheimer analyst Hartaj Singh maintained a Buy rating on aTyr Pharma (LIFE – Research Report) today and set a price
SAN DIEGO, April 21, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathwa
NEW YORK, NY / ACCESSWIRE / April 13, 2020 / Levi & Korsinsky announces it has commenced an investigation of aTyr Pharma, Inc. (NASDAQ:LIFE) concerning possible breaches of fiduciary duty. To obtain a
The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance
12:02pm, Friday, 27'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.None of the NYSE- or Nasdaq-listed biotech stocks hit 52 week highs Thursday.Down In The Dumps (Biotech Stocks Hitting
Atyr Pharma (LIFE) Reports Q4 Loss, Beats Revenue Estimates (Revised)
11:35am, Friday, 27'th Mar 2020
Atyr Pharma (LIFE) delivered earnings and revenue surprises of 3.14% and 69.41%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Oppenheimer Maintains a Buy Rating on aTyr Pharma (LIFE)
11:32am, Friday, 27'th Mar 2020
Oppenheimer analyst
Hartaj Singh
maintained a
Buy
rating on aTyr Pharma (
LIFE
–
Research Report
) today and set a price target of
$8.00
. The company’s shares closed last Monday at $3.08, close t
aTyr Pharma Announces Fourth Quarter and Full Year 2019 Results and Provides Corporate Update
08:01pm, Thursday, 26'th Mar 2020
Company to host conference call and webcast today at 5:00 p.m. EDT / 2:00 p.m. PDT SAN DIEGO, March 26, 2020 -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company.
aTyr Pharma, Inc. to Host Earnings Call
07:00pm, Thursday, 26'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 26, 2020 / aTyr Pharma, Inc. (NASDAQ:LIFE) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 26, 2020 at 5:00 P
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 25.) * Ra Pharmaceuticals Inc (NASDAQ: RARX)Down In The
SAN DIEGO, March 24, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathwa
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
aTyr Pharma to Announce Fourth Quarter and Full Year End 2019 Financial Results on March 26th
08:05pm, Thursday, 19'th Mar 2020
SAN DIEGO, March 19, 2020 -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel.
Leading Cancer Researcher Dr. Arthur M. Mercurio Joins aTyr as Scientific Advisor
12:30pm, Tuesday, 17'th Mar 2020
SAN DIEGO, March 17, 2020 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathwa
